Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor beta constant region 1 (TRBC1) is one of two highly homologous constant regions (TRBC1 and TRBC2) encoded within the TCR beta chain locus. The TCR is a membrane-bound heterodimeric receptor found on T-cell surfaces, essential for recognizing peptide antigens presented by major histocompatibility complex (MHC) molecules. The constant region (C-region), though not directly involved in antigen recognition, provides structural stability and mediates key interactions with other molecules in the TCR signaling complex. Each T cell expresses a TCR containing either TRBC1 or TRBC2, but not both. TRBC1 has become a diagnostic and therapeutic target due to the development of monoclonal antibodies that selectively bind this region. This specificity enables detection and quantification of clonal T-cell populations in malignancies (e.g., T-cell lymphoma/leukemia), facilitates minimal residual disease (MRD) monitoring, and represents an avenue for targeted immunotherapy, such as CAR-T cell designs that aim to eradicate malignant TRBC1+ T cells while preserving normal immune function[3][4][5][7].
Monoclonal antibodies bind specifically to TRBC1 to identify or deplete clonal T-cell populations\nCAR-T cell therapies target TRBC1-expressing malignant T cells, sparing TRBC2-expressing normal T cells
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor beta constant region 1 (TRBC1).